Uploaded January 2024 | Updated September 2026, 4 hours ago
In the inaugural lecture of the 2024 Centennial Front Row series, President and CEO Peter Schultz illuminates how Scripps Research is building on its storied past—a remarkable century of discovery and innovation—to establish a new paradigm for the future of science and medicine. Under Schultz’s leadership, Scripps Research is expanding its global impact by empowering exceptional scientists to pursue groundbreaking ideas and seamlessly blending curiosity-fueled science with impact-driven drug discovery. Schultz shares how this unique approach is already giving rise to a new generation of first-in-class medicines against cancers, heart disease, deadly pathogens, neurological disorders, and many other health threats.
Learn more: https://www.scripps.edu/
In the inaugural lecture of the 2024 Centennial Front Row series, President and CEO Peter Schultz illuminates how Scripps Research is building on its storied past—a remarkable century of discovery and innovation—to establish a new paradigm for the future of science and medicine. Under Schultz’s leadership, Scripps Research is expanding its global impact by empowering exceptional scientists to pursue groundbreaking ideas and seamlessly blending curiosity-fueled science with impact-driven drug discovery. Schultz shares how this unique approach is already giving rise to a new generation of first-in-class medicines against cancers, heart disease, deadly pathogens, neurological disorders, and many other health threats.
Learn more: https://www.scripps.edu/
